Core Business Areas
BioLife focuses on the following core business areas to support two-way healthcare market entry between the U.S. and China, helping products, technologies, clinical data resources, supply chain capabilities, and partnerships move toward more effective cross-border coordination and commercialization.
Medical Consumables & Clinical Supply Chain
Built on our long-standing experience in medical consumables and supply chain execution, we support clinically relevant and cost-advantaged products in cross-border market entry, supply chain coordination, channel collaboration, and commercialization, including disposable endoscopy-related and other clinical products.
Commercialization of U.S.-Cleared Medical Devices & Specialty Products
For mature medical devices, AI-assisted products, and specialty equipment that have already obtained U.S. market clearance, we support channel expansion, key account development, market education, and commercialization execution to help products achieve more efficient market adoption.
Advanced Manufacturing in China & Cross-Border Industrialization
Leveraging the combined strengths of advanced manufacturing in China in quality, efficiency, and cost, we support overseas technologies, products, and brands in connecting with Chinese manufacturing and industrialization resources, enabling ODM / OEM, joint development, production execution, supply chain coordination, and cross-border commercialization.
and partners seeking manufacturing execution in China
Research Imaging & Advanced Equipment Collaboration Platform
We help advanced imaging and frontier research equipment with strong technical value and cost advantages enter U.S. research settings, combining expert collaboration between the U.S. and China, joint research, publication support, and grant development to build pathways from research collaboration toward clinical translation.
Research equipment companies
advanced imaging technology developers
translational collaboration partners
Clinical Data Collaboration & Real-World Evidence
Centered on U.S. clinical data collaboration, real-world evidence, and data-driven research support, we help relevant technologies, AI systems, medical devices, and innovative programs explore more evidence-grounded pathways for research validation, market entry, and commercialization. For opportunities that require a better understanding of the U.S. clinical data environment, research feasibility, and evidence-generation logic, .we can work with leading U.S. clinical data platform partners and resources to support more practical pathway design and coordinated execution.
advanced equipment developers
Overseas teams seeking to understand U.S. real-world evidence pathways
Commercialization of Health Management, Wellness & Longevity Solutions
Centered on supplements, health products, traditional Chinese medicine concepts, and integrated health management, we explore commercially viable projects that address growing demand in wellness, functional improvement, and longevity management, building differentiated health solutions for the market.
Strategic Collaboration & Capital Alignment
In addition to the core business areas above, BioLife also brings capabilities in strategic collaboration, resource integration, and capital alignment. Supported by three affiliated funds and years of cross-border experience, we are able to support deeper strategic coordination and long-term value creation in suitable projects and partnership opportunities.
Learn More:
Affiliated Fund Management Platform